Evidence map›Paper›PMID 32631428›Full record

SynthesisJournal of cardiothoracic surgery2020

The treatments and postoperative complications of esophageal cancer: a review.

Qi-Liang Xu, Hua Li, Ye-Jing Zhu, Geng Xu

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of cardiothoracic surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. NewInternational journal of molecular sciences · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Precision Imaging for Early Detection of Esophageal Cancer.Bioengineering (Basel, Switzerland) · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Qi-Liang XuDepartment of Cardiothoracic Surgery, Heze Municipal Hospital, Heze, 274031, Shandong, China.
Hua LiDepartment of Information, Heze Municipal Hospital, Heze, 274031, Shandong, China.
Ye-Jing ZhuDepartment of Clinical Pharmacy, Heze Municipal Hospital, Heze, 274031, Shandong, China.
Geng XuDepartment of Cardiothoracic Surgery, Heze Municipal Hospital, Heze, 274031, Shandong, China. xuslyy3278@163.com.ORCID http://orcid.org/0000-0003-2954-9366

Funding

the scientific research program funding fund of Heze municipal hospital, China No.2019A0020
6 · The paper itself

Abstract

Esophageal cancer is still one of the most common cancers in the world. We review the appropriate treatments at different stages of esophageal cancer and also analyze the advantages and disadvantages of these treatments. The prognosis and recovery of different treatment regimens are further discussed. In particular, post-operative complications are the major causes of high mortality derived from the esophageal cancer. Therefore, we particularly discuss the main complications resulting in high mortality after surgery of esophageal cancer, and summarize their risk factors and treatment options.

backgroundAs the common cancer, the complications of esophageal cancer after surgery have been not obtained systematic treatment strategy, focusing on treatment regimens based on the different stages of esophageal cancers. METHODS AND OVERVIEW: This paper systematically summarizes the appropriate treatment strategies for different stages of esophageal cancers, and their advantages and disadvantages. We particularly focus on the postoperative survival rate of patients and postoperative complications, and discuss the causes of high mortality risk factors after surgery. The risk factors of death and corresponding treatment methods are further summarized in this study.

conclusionPostoperative complications is the main cause responsible for the hard cure of esophageal cancers. The existing literatures indicate that postoperative anastomotic fistula is one of the most important complications leading to death, while it has not received much attention yet. We suggest that anastomotic fistula should be detected and dealt with early by summarizing these literatures. It is, therefore, necessary to develop a set of methods to predict or check anastomotic fistula in advance.

Indexed as

AdenocarcinomaAnastomosis, SurgicalCarcinoma, Squamous CellEsophageal NeoplasmsEsophagectomyHumansNeoplasm StagingPostoperative ComplicationsRetrospective StudiesRisk FactorsAnastomotic fistulaDiagnosisEsophageal cancerPostoperative complicationsRisk factors

Identifiers

PMID32631428
PMCPMC7336460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.